Prophylactic antibiotics cannot prevent endoscopic retrograde cholangiopancreatography-induced cholangitis: A meta-analysis

Pancreas

Volumn 38, Issue 2, 2009, Pages 126-130

  Bai, Yu ^a,b   Gao, Fei ^a   Gao, Jun ^a,b   Zou, Duo Wu ^a   Li, Zhao Shen ^a,b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Antibiotics; ERCP induced cholangitis; Meta analysis

Indexed keywords

ANTIBIOTIC AGENT; CEFONICID; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CLINDAMYCIN; GENTAMICIN; PIPERACILLIN;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BILE DUCT OBSTRUCTION; CHOLANGITIS; CLINICAL TRIAL; COCHRANE LIBRARY; DRUG TREATMENT FAILURE; EMBASE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; INCIDENCE; INFECTION PREVENTION; MEDLINE; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SCISEARCH; SENSITIVITY ANALYSIS; SEPSIS; SYSTEMATIC REVIEW;

ANTIBIOTIC PROPHYLAXIS; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGITIS; HUMANS; SEPSIS;

EID: 65349099333     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e318189fl6d     Document Type: Article

References (25)

1. Bilbao MK, Dotter CT, Lee TG, et al. Complications of endoscopic retrograde cholangiopancreatography. A study of 10,000 cases. Gastroenterology. 1976;70:314-320.
2. Freeman M, Nelson D, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996;335: 909-918.
3. Loperfido S, Giampaolo A, Benedetti G, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc. 1998;48:1-10.
4. Vaira D, D'Anna L, Ainley C, et al. Endoscopic sphincterotomy in 1000 consecutive patients. Lancet. 1989;2:431-433.
5. Hirota WK, Petersen K, Baron TH, et al. Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy. Guidelines for antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc. 2003;58:475-482.
6. Wilson W, Taubert KA, Gewitz M, et al. American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; Council on Cardiovascular Surgery and Anesthesia; Quality of Care and Outcomes Research Interdisciplinary Working Group. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. J Am Dent Assoc. 2007;138: 739-760.
7. Harris A, Chan AC, Torres-Viera C, et al. Meta-analysis of antibiotic prophylaxis in endoscopic retrograde cholangiopancreatography (ERCP). Endoscopy. 1999;31:718-724.
8. Räty S, Sand J, Pulkkinen M, et al. Post-ERCP pancreatitis: reduction by routine antibiotics. J Gastrointest Surg. 2001;5:339-345.
9. Llach J, Bordas JM, Almela M, et al. Prospective assessment of the role of antibiotic prophylaxis in ERCP. Hepatogastroenterology. 2006;53:540-542.
10. Begg CB. Publication bias. In: Cooper H, Hedges LV, eds. The Handbook of Research Synthesis. New York, NY: Russell Sage Foundation; 1994:399-410.
11. Byl B, Deviere J, Struelens MJ, et al. Antibiotic prophylaxis for infectious complications after therapeutic endoscopic retrograde cholangiopancreatography: a randomized, double blind, placebo-controlled study. Clin Infect Dis. 1995;20:1236 -1240.
12. Brandes JW, Scheffer B, Lorenz-Meyer H, et al. ERCP: complications and prophylaxis. A controlled study. Endoscopy. 1981;13:27-30.
13. Smith BC, Alqamish JR, Watson KJ, et al. Preventing endoscopic retrograde cholangiopancreatography related sepsis: a randomized controlled trial comparing two antibiotic regimes. J Gastroenterol Hepatol. 1996;11:938-941.
14. Mehal WZ, Culshaw KD, Tillotson GS, et al. Antibiotic prophylaxis for ERCP: a randomized clinical trial comparing ciprofloxacin and cefuroxime in 200 patients at high risk of cholangitis. Eur J Gastroenterol Hepatol. 1995;7:841-845.
15. Davis AJ, Kolios G, Alveyn CG, et al. Antibiotic prophylaxis for ERCP: a comparison of oral ciprofloxacin with intravenous cephazolin in the prophylaxis of high-risk patients. Aliment Pharmacol Ther. 1998;12:207-211.
16. Sauter G, Grabein B, Huber G, et al. Antibiotic prophylaxis of infectious complications with endoscopic retrograde cholangiopancreatography. A randomized controlled study. Endoscopy. 1990;22:164-167.
17. Niederau C, Polmann U, Lubke H, et al. Prophylactic antibiotic treatment in therapeutic or complicated diagnostic ERCP: results of a randomized controlled clinical study. Gastrointest Endosc. 1994;40:533-537.
18. Finkelstein R, Yassin K, Suissa A, et al. Failure of cefonicid prophylaxis for infectious complications related to endoscopic retrograde cholangiopancreatography. Clin Infect Dis. 1996;23:378-379.
19. Hazel SJ, Speelman P, Dankert J, et al. Piperacillin to prevent cholangitis after endoscopic retrograde cholangiopancreatography. A randomized, controlled trial. Ann Intern Med. 1996;125:442-447.
20. Lorenz R, Lehn N, Born P, et al. Antibiotic prophylaxis using cefuroxime in bile duct endoscopy. Dtsch Med Wochenschr. 1996;121:223-230.
21. Low DE, Mieflikier AB, Kennedy JK, et al. Infectious complications of endoscopic retrograde cholangiopancreatography. A prospective assessment. Ann Intern Med. 1980;140:1076-1077.
22. Stray N, Midtvedt T, Valnes K, et al. Endoscopy related bacteremia. Scand J Gastroenterol. 1978;13(3):345-347.
23. Cotton PB, Connor P, Rawls E, et al. Infection after ERCP and antibiotic prophylaxis: a sequential quality-improvement approach over 11 years. Gastrointest Endosc. 2008;67:471-475.
24. Polydorou AA, Cairns SR, Dowsett JF, et al. Palliation of proximal malignant biliary obstruction by endoscopic endoprosthesis insertion. Gut. 1991;32:685-689.
25. De Palma GD, Galloro G, Siciliano S, et al. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. Gastrointest Endosc. 2001;53:547-553.